China Traditional Chinese Medicine Holdings (HKG:0570) expects its 2024 net profit to decrease by 90% to 100% year over year, according to a filing with the Hong Kong bourse.
The traditional Chinese medicine maker attributed the downbeat forecast to lower sales, credit, goodwill, plant impairment, and remedial taxes paid by subsidiaries.
The company is expected to publish its annual report by March 31.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.